aspartic acid has been researched along with Chronic Hepatitis B in 8 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 7.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "A total of 319 chronic hepatitis B patients who received lamivudine therapy for more than a year were enrolled in this study." | 7.78 | Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment. ( Wu, F; Wu, MJ; Zhu, B; Zhu, SM; Zhuge, XL, 2012) |
| "Enzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation." | 3.96 | Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. ( Baik, GH; Bang, CS; Choi, EY; Ham, YL; Kim, DJ; Kim, HJ; Kim, SY; Shin, SP; Suk, KT; Yang, YJ, 2020) |
| "In the current study we aimed to show the common YMDD motif mutations in viral polymerase gene in chronic hepatitis B patients during lamivudine and adefovir therapy." | 3.79 | Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population. ( Alagozlu, H; Coskun, M; Koksal, B; Ozdemir, O; Yilmaz, A, 2013) |
| "A total of 319 chronic hepatitis B patients who received lamivudine therapy for more than a year were enrolled in this study." | 3.78 | Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment. ( Wu, F; Wu, MJ; Zhu, B; Zhu, SM; Zhuge, XL, 2012) |
| "To establish a rapid and accurate method for the detection of lamivudine-resistant mutations in hepatitis B virus and monitor of lamivudine resistance during lamivudine treatment in patients with chronic hepatitis B virus infection." | 3.73 | Detection of YMDD mutants using universal template real-time PCR. ( Han, B; Wang, RS; Yang, ZJ; Zhang, H; Zhu, YF, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Wai-Sun Wong, V | 1 |
| Kao, JH | 1 |
| Li, ZC | 1 |
| Li, Z | 1 |
| Li, C | 1 |
| Fang, JC | 1 |
| Li, XZ | 1 |
| Zhao, YN | 1 |
| Liang, CY | 1 |
| Kim, HJ | 1 |
| Kim, SY | 1 |
| Shin, SP | 1 |
| Yang, YJ | 1 |
| Bang, CS | 1 |
| Baik, GH | 1 |
| Kim, DJ | 1 |
| Ham, YL | 1 |
| Choi, EY | 1 |
| Suk, KT | 1 |
| Alagozlu, H | 1 |
| Ozdemir, O | 1 |
| Koksal, B | 1 |
| Yilmaz, A | 1 |
| Coskun, M | 1 |
| Wu, F | 1 |
| Wu, MJ | 1 |
| Zhuge, XL | 1 |
| Zhu, SM | 1 |
| Zhu, B | 1 |
| Shindo, M | 1 |
| Hamada, K | 1 |
| Nishioji, K | 1 |
| Muramatsu, A | 1 |
| Oda, Y | 1 |
| Okuno, T | 1 |
| Yuen, MF | 1 |
| Wong, DK | 1 |
| Sum, SS | 1 |
| Yuan, HJ | 1 |
| Yuen, JC | 1 |
| Chan, AO | 1 |
| Wong, BC | 1 |
| Lai, CL | 1 |
| Wang, RS | 1 |
| Zhang, H | 1 |
| Zhu, YF | 1 |
| Han, B | 1 |
| Yang, ZJ | 1 |
1 trial available for aspartic acid and Chronic Hepatitis B
| Article | Year |
|---|---|
Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection.
Topics: Adolescent; Adult; Amino Acid Motifs; Anti-HIV Agents; Aspartic Acid; DNA, Circular; DNA, Viral; Fem | 2005 |
7 other studies available for aspartic acid and Chronic Hepatitis B
| Article | Year |
|---|---|
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection-Authors' reply.
Topics: Alanine Transaminase; Asia, Eastern; Aspartate Aminotransferases; Aspartic Acid; Carcinoma, Hepatoce | 2020 |
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection.
Topics: Alanine Transaminase; Asia, Eastern; Aspartate Aminotransferases; Aspartic Acid; Carcinoma, Hepatoce | 2020 |
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.
Topics: Alanine; Alanine Transaminase; Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Biopsy; Hepat | 2020 |
Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
Topics: Adenine; Adult; Aged; Amino Acid Motifs; Anti-HIV Agents; Antiviral Agents; Aspartic Acid; Case-Cont | 2013 |
Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Antiviral Agents; Aspartic Acid; China; DNA, Viral; | 2012 |
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartic Acid; DNA, Viral; Drug Resistance, Viral; Fe | 2004 |
Detection of YMDD mutants using universal template real-time PCR.
Topics: Antiviral Agents; Aspartic Acid; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Hepati | 2006 |